Low plasma levels of vitamin B6 are independently associated with a heightened risk of deep-vein thrombosis

被引:68
作者
Cattaneo, M [1 ]
Lombardi, R [1 ]
Lecchi, A [1 ]
Bucciarelli, P [1 ]
Mannucci, PM [1 ]
机构
[1] Univ Milan, Osped Maggiore, IRCCS,Dept Internal Med, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
关键词
thrombosis; risk factors; veins; homocysteine; vitamin B-6;
D O I
10.1161/hc4501.098925
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Elevated plasma levels of total homocysteine (tHcy) before and after an oral methionine load (PML) are associated with an elevated risk of deep-vein thrombosis (DVT). We investigated whether plasma levels of B vitamins that are involved in Hcy metabolism are associated with an elevated risk of DVT. Methods and Results-We compared 397 cases with previous DVT with 585 matched healthy controls. The plasma levels of folate, vitamin B-12, vitamin B-6, and fasting and PML tHcy were measured. The ORs for DVT associated with high (> 95th percentile) fasting levels and PML increases of tHcy were 2.1 (95% CI, 1.2 to 3.4) and 2.4 (95% CI, 1.5 to 3.9) after adjustment for established risk factors for DVT. Fasting plasma levels and PML increases in tHcy correlated negatively with vitamin levels. The crude OR for folate levels in the lowest quartile compared with the highest was 1.5 (95% CI, 1.1 to 2.1), and that for B-6 levels in the lowest and second quartiles compared with the highest was 1.5 (95% CI, 1.0 to 2.1). However, after adjustment for established risk factors and fasting and PML tHcy, the ORs for B-6 levels in the lowest and second quartiles only remained statistically significant (lowest quartile: OR, 1.8; 95% Cl, 1.2 to 2.8, second quartile, OR, 1.9; 95% CI, 1.3 to 2.9). Conclusions-High fasting and PML tHcy and low vitamin B-6 plasma levels are associated with an elevated risk for DVT independently of established risk factors for DVT. The association of low vitamin B, levels with the risk for DVT is independent of fasting and PML tHcy levels.
引用
收藏
页码:2442 / 2446
页数:5
相关论文
共 34 条
  • [1] NOVEL FUNCTIONS OF VITAMIN-B-6
    BENDER, DA
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (03) : 625 - 630
  • [2] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
    BOUSHEY, CJ
    BERESFORD, SAA
    OMENN, GS
    MOTULSKY, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057
  • [3] BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
  • [4] The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels
    Cattaneo, M
    Chantarangkul, V
    Taioli, E
    Santos, JH
    Tagliabue, L
    [J]. THROMBOSIS RESEARCH, 1999, 93 (01) : 1 - 8
  • [5] Cattaneo M, 1999, THROMB HAEMOSTASIS, V81, P165
  • [6] Is the oral methionine loading test insensitive to the remethylation pathway of homocysteine?
    Cattaneo, M
    Lombardi, R
    Lecchi, A
    Zighetti, ML
    [J]. BLOOD, 1999, 93 (03) : 1118 - 1119
  • [7] A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (Factor V:Q(506))
    Cattaneo, M
    Tsai, MY
    Bucciarelli, P
    Taioli, E
    Zighetti, ML
    Bignell, M
    Mannucci, PM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) : 1662 - 1666
  • [8] Cattaneo M., 1998, Netherlands Journal of Medicine, V52, pS21
  • [9] den Heijer M, 1998, THROMB HAEMOSTASIS, V80, P874
  • [10] Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566